GL1X · GenesisL1 explorer

Ligand · 0FT

0FT · 1-{[1-(alpha-L-arabinofuranosyl)-1H-1,2,3-triazol-4-yl]methyl}-5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine

0FT, 1-{[1-(alpha-L-arabinofuranosyl)-1H-1,2,3-triazol-4-yl]methyl}-5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine (C13 H17 N5 O6, 339.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…

Component
0FT
Formula
C13 H17 N5 O6
Class
ligand
Structures
2
PDB entries
1

Binding sites

0FT in 2 structures; the first of them:

  • 4G8Y · Crystal structure of Ribonuclease A in complex with 5b · 0FT A201 · binds LYS7, GLN11, HIS12, LYS41, VAL43, ASN44, THR45, LYS66 and 7 more
  • 4G8Y · Crystal structure of ribonuclease a in complex with 5B · 0FT A201 · binds LYS7, GLN11, HIS12, LYS41, VAL43, ASN44, THR45, LYS66 and 7 more

Residues it binds most

LYS 2, ASP 2, HIS 2, VAL 2, ALA 2, ASN 2, GLN 2, PHE 2, SER 2, THR 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.